Advancing
Peptide
Therapies
» Press Releases
9-Nov-2009
Unigene Announces Financial Results for Third Quarter 2009
4-Nov-2009
Unigene to Release Third Quarter 2009 Results and Host Conference Call
20-Oct-2009
Unigene to Host Conference Call to Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics
20-Oct-2009
Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics
Concept
to
Commercialization

» Why Unigene

» Our Products

» Stock Quote

» Events

© Copyright 2005-2008 Unigene, Inc. ▪ Legal